These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 343887)

  • 1. [Effects of mazindol on some parameters of energy metabolism regulation in weight reduction of obese subjects (author's transl)].
    Rath R; Vondra K; Bass A; Kujalová V
    Bratisl Lek Listy; 1978 Feb; 69(2):170-9. PubMed ID: 343887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Salivary test as the index of appetite inhibition during treatment of obesity (author's transl)].
    Zahorska-Markiewicz B
    Przegl Lek; 1980; 37(2):313-5. PubMed ID: 6988901
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of mazindol on metabolic and regulatory changes in obese women during weight reduction.
    Rath R; Vondra K; Bass A; Kujalova V; Wenkeova J
    Int J Obes; 1979; 3(2):133-40. PubMed ID: 93588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results in the treatment of obesity by Mazindol (AN 448 Sandoz) in hospitalized subjects using the method of double-blind trial (author's transl)].
    Kreze A; Velemínsky J; Toman A
    Bratisl Lek Listy; 1976 May; 65(5):537-43. PubMed ID: 788862
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of acute administration of mazindol on brain energy metabolism in adult mice.
    Gonçalves CL; Scaini G; Rezin GT; Jeremias IC; Bez GD; Daufenbach JF; Gomes LM; Ferreira GK; Zugno AI; Streck EL
    Acta Neuropsychiatr; 2014 Jun; 26(3):146-54. PubMed ID: 25142190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mazindol, an anorectic of a new series, in the treatment of obesity (author's transl)].
    Dolecek R
    Cas Lek Cesk; 1975 Feb; 114(8):249-54. PubMed ID: 1095197
    [No Abstract]   [Full Text] [Related]  

  • 7. Extra-anorectic actions of mazindol.
    Jonderko K; Kucio C
    Isr J Med Sci; 1989 Jan; 25(1):20-4. PubMed ID: 2925353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermogenic properties of ciclazindol and mazindol in rodents.
    Wyllie MG; Fletcher A; Rothwell NJ; Stock MJ
    Int J Obes; 1984; 8 Suppl 1():85-92. PubMed ID: 6534897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of serum lipid values and of the neurovegetative equilibrium in subjects under mazindol therapy].
    Zdichynec B; Rechmani BA
    Cesk Gastroenterol Vyz; 1979 Jan; 33(1):51-7. PubMed ID: 369713
    [No Abstract]   [Full Text] [Related]  

  • 10. Endocrine studies with mazindol in obese patients.
    Dolecek R
    Pharmatherapeutica; 1980; 2(5):309-16. PubMed ID: 6776543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of mazindol on obesity induced by administration of gold thioglucose].
    Ohminami K; Matsuoka E; Takahashi Y; Shimizu D; Okuda H
    Nihon Yakurigaku Zasshi; 1984 Feb; 83(2):123-32. PubMed ID: 6430760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the effect of mazindol on the metabolism and lipolysis in obese women].
    Kucio C; Zahorska-Markiewicz B; Piskorska D; Semenowicz-Siuda K; Waluga M
    Pol Arch Med Wewn; 1987 Mar; 77(3):73-6. PubMed ID: 3275392
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activity-mobilizing lipids and blood lipids in patients treated with Mazindol].
    Hasik J; Gryczka AZ; Paluszak J; Tycowa M
    Pol Arch Med Wewn; 1978 Nov; 60(5):401-4. PubMed ID: 724542
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)].
    Gołebiowska M; Chlebna-Sokół D; Kobierska I; Konopińska A; Małek M; Mastalska A; Zwaigzne-Raczyńska J
    Przegl Lek; 1981; 38(3):355-8. PubMed ID: 7017827
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of action of mazindol in preventing onset and development of obesity induced by gold thioglucose injection.
    Kawano-Takahashi Y; Ohminaji H; Ubagai E; Okuda H
    Int J Obes; 1984; 8(6):655-64. PubMed ID: 6442712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mazindol on carbohydrate and insulin metabolism in obesity.
    Harrison LC; King-Roach AP; Sandy KC
    Metabolism; 1975 Dec; 24(12):1353-65. PubMed ID: 1196130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of obesity with mazindol (author's transl)].
    Escher M
    Schweiz Rundsch Med Prax; 1976 Jun; 65(24):751-4. PubMed ID: 981189
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
    Riesco J; Troncoso G; Costamaillere L; Rodríguez J
    Rev Med Chil; 1977 Jun; 105(6):375-9. PubMed ID: 331428
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mazindol in the treatment of obese diabetic patients].
    Dolecek R; Reil P; Skarpová O; Závada M
    Vnitr Lek; 1976 Aug; 22(8):798-804. PubMed ID: 788327
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of an anorectic agent, AN 448 on weight reduction and plasma lipids.
    Ishikawa T; Nakaya N; Nakamura H; Goto Y
    Keio J Med; 1975 Jul; 24(3):211-8. PubMed ID: 1219154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.